{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "438",
                "508"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wada wrodzona serca pod postaci\u0105 ubytku przegrody mi\u0119dzyprzedsionkowej"
        },
        {
            "identifier": "T2",
            "position": [
                "629",
                "638"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Tiopental"
        },
        {
            "identifier": "T3",
            "position": [
                "641",
                "657"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "5 % glukoza wlew"
        },
        {
            "identifier": "T4",
            "position": [
                "884",
                "906"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "leczenia  operacyjnego"
        },
        {
            "icd": "ICD10:Q21.1",
            "identifier": "N1",
            "referenced": "T1",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzyprzedsionkowej"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 3 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Wada wrodzona serca pod postaci\u0105 ubytku przegrody mi\u0119dzyprzedsionkowej.\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nTiopental., 5 % glukoza wlew.\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka  3  letnia w  stanie  dobrym  zosta\u0142a  przyj\u0119ta  do  Kliniki    celem  kwalifikacji  do  leczenia  operacyjnego.\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:13.58[10\\\\^3/ul]\n    RBC:4.74[10\\\\^6/ul]\n    HGB:13.7[g/dl]\n    HCT:39.6[%]\n    MCV:83.5[fl]\n    MCH:28.9[pg]\n    MCHC:34.6[g/dl]\n    PLT:369.0[10\\\\^3/ul]\n    RDW-SD:35.7[fl]\n    RDW-CV:11.8[%]\n    PDW:10.6[fl]\n    MPV:9.6[fl]\n    P-LCR:21.3[%]\n    PCT:0.3[%]\n    NEUTR#:1.51[10\\\\^3/ul]\n    NEUTR%:11.1[%]\n    LYMPH#:11.04[10\\\\^3/ul]\n    LYMPH%:81.3[%]\n    MONO#:0.69[10\\\\^3/ul]\n    MONO%:5.10[%]\n    EO#:0.28[10\\\\^3/ul]\n    EO%:2.10[%]\n    BASO#:0.06[10\\\\^3/ul]\n    BASO%:0.40[%]\n    NRBC %:0.10[%]\n    NRBC#:0.01[10\\\\^3/ul]\nMorfologia\n    WBC:6.87[10\\\\^3/ul]\n    RBC:4.50[10\\\\^6/ul]\n    HGB:13.1[g/dl]\n    HCT:38.0[%]\n    MCV:84.4[fl]\n    MCH:29.1[pg]\n    MCHC:34.5[g/dl]\n    PLT:235.0[10\\\\^3/ul]\n    RDW-SD:35.8[fl]\n    RDW-CV:11.8[%]\n    PDW:11.0[fl]\n    MPV:9.9[fl]\n    P-LCR:23.6[%]\n    PCT:0.2[%]\n    NEUTR#:2.76[10\\\\^3/ul]\n    NEUTR%:40.1[%]\n    LYMPH#:3.20[10\\\\^3/ul]\n    LYMPH%:46.6[%]\n    MONO#:0.83[10\\\\^3/ul]\n    MONO%:12.10[%]\n    EO#:0.06[10\\\\^3/ul]\n    EO%:0.90[%]\n    BASO#:0.02[10\\\\^3/ul]\n    BASO%:0.30[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nABL Parametry krytyczne\n    pH:7.409\n    pCO2:29.5[mmHg]\n    BE:-4.70[mmol/L]\n    HCO3:18.3[mmol/L]\n    pO2:68.1[mmHg]\n    O2Sat:95.2[%]\n    Na - ABL:139[mmol/L]\n    K - ABL:4.3[mmol/L]\n    Cl - ABL:112[mmol/L]\n    Ca zj ABL:1.32[mmol/L]\n    Ht - ABL:43.5[%]\n    Hb ABL:14.2[g/dl]\n    FO2Hb:93.4[%]\n    FCOHb:1.2[%]\n    FMetHb:0.7[%]\n    FHbF - ABL:0.00[%]\n    GLU-ABL:99[mg/dl]\n    mleczany:15[mg/dl]\n    COMMENT_HL7:\nABL Parametry krytyczne\n    pH:7.406\n    pCO2:30.3[mmHg]\n    BE:-4.60[mmol/L]\n    HCO3:18.7[mmol/L]\n    pO2:43.7[mmHg]\n    O2Sat:78.2[%]\n    Na - ABL:142[mmol/L]\n    K - ABL:3.9[mmol/L]\n    Cl - ABL:113[mmol/L]\n    Ca zj ABL:1.10[mmol/L]\n    Ht - ABL:35.8[%]\n    Hb ABL:11.6[g/dl]\n    FO2Hb:77.3[%]\n    FCOHb:0.7[%]\n    FMetHb:0.4[%]\n    FHbF - ABL:*[%]\n    GLU-ABL:70[mg/dl]\n    mleczany:15[mg/dl]\n    COMMENT_HL7:\nImmununochemia -Immulite: COMMENT_HL7:\nFibrynogen (F): FIB:2.15[g/L]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:34.8[s]\nINR: INR:1.2\nCzas protrombinowy (PT): PT:13.5[s]\nCzas trombinowy (TT): TT:15.9[s]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nBia\u0142ko CRP: CRP:1.00[mg/dl]\nWska\u017anik PT: PT%:81[%]\nKreatynina: CREA:0.30[mg/dl]\nMocznik: UREA:28.00[mg/dl]\nASPAT: AST:34.00[IU/L]\nALAT: ALT:22.00[IU/L]\nNT- proBNP: NTpBNP:156.00[pg/ml]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:117.0[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:85[cm]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:155.8[ml/min/1,73m2]\nPr\u00f3ba zgodno\u015bci (kontrola grupy krwi biorcy)\n    NR-KS:K18/000114\n    DONACJA:Z511318000013\n    DONACJA:Z510017023481\n------------------------------------------------\nICD10\n------------------------------------------------\nQ21.1\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n87.440\n88.761\n------------------------------------------------"
}